ArticleTropical medicine and infectious disease2023
Evaluation of Laboratories Supporting Invasive Bacterial Vaccine-Preventable Disease (IB-VPD) Surveillance in the World Health Organization African Region, through the Performance of Coordinated External Quality Assessment.
Inacio Mandomando, Jason M Mwenda, Tomoka Nakamura, Linda de Gouveia, Anne von Gottberg, Brenda A Kwambana-Adams, Martin Antonio, Augusto Messa, David Litt, Shila Seaton and 3 more
Article in Tropical medicine and infectious disease, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 28% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
1 citing paper in PubMed, 3 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
13 authors at 10 institutions in 10 countries.
Inacio MandomandoCentro de Investigação em Saúde de Manhiça (CISM), Maputo P.O. Box 1929, Mozambique.ORCID 0000-0002-1078-2187
Jason M MwendaWorld Health Organization (WHO), Regional Office for Africa, Brazzaville P.O. Box 06, Congo.
Tomoka NakamuraDepartment of Infectious Disease Epidemiology, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK.ORCID 0000-0002-2623-2075
Linda de GouveiaCentre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases, National Health Laboratory Service, Johannesburg 2131, South Africa.
Anne von GottbergCentre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases, National Health Laboratory Service, Johannesburg 2131, South Africa.
Brenda A Kwambana-AdamsMedical Research Council Unit The Gambia at the London School of Hygiene and Tropical Medicine, Banjul P.O. Box 273, The Gambia.
Martin AntonioMedical Research Council Unit The Gambia at the London School of Hygiene and Tropical Medicine, Banjul P.O. Box 273, The Gambia.
Augusto MessaCentro de Investigação em Saúde de Manhiça (CISM), Maputo P.O. Box 1929, Mozambique.ORCID 0000-0002-1794-2462
David LittRespiratory and Vaccine Preventable Bacteria Reference Unit, United Kingdom Health Security Agency (Formerly Public Health England), London NW9 5EQ, UK.
Shila SeatonUnited Kingdom National External Quality Assessment Service (UK NEQAS) for Microbiology, United Kingdom Health Security Agency (Formerly Public Health England), London NW9 1GH, UK.
Goitom Gebremedhin WeldegebrielWorld Health Organization (WHO), Inter Country Support Team (IST), Harare P.O. Box 5160, Zimbabwe.ORCID 0000-0002-0535-3484
Joseph Nsiari-Muzeyi BieyWorld Health Organization (WHO), Inter Country Support Team (IST), Ouagadougou 03 BP 7019, Burkina Faso.
Fatima SerhanDepartment of Immunization, Vaccines and Biologicals, World Health Organization, 1202 Geneva, Switzerland.
Manhiça Health Research Centre · MZNational Health Laboratory Service · ZAPublic Health England · GBLiverpool School of Tropical Medicine · GBLondon School of Hygiene & Tropical Medicine · GBUniversity of London · GBWest African Health Organisation · BFWorld Health Organization · CHWorld Health Organization Regional Office for Africa · CGWorld Health Organization - Zimbabwe · ZW
Funding
World Health Organization 001
6 · The paper itself
Abstract
(1) Background: Laboratories supporting the invasive bacteria preventable disease (IB-VPD) network are expected to demonstrate the capacity to identify the main etiological agents of pediatric bacterial meningitis (PBM) (
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Evaluation of Laboratories Supporting Invasive Bacterial Vaccine-Preventable Disease (IB-VPD) Surveillance in the World Health Organization African Region, through the Performance of Coordinated External Quality Assessment. · full record | OpenQuestion